GSE89154 proscillaridin 1 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE89154_proscillaridin_1_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE89154_proscillaridin_1_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE89154_proscillaridin_1_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE89154_proscillaridin_1_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

HLA complex P5

Gene

H3 clustered histone 7

Gene

MSL complex subunit 3B

Gene

H2A clustered histone 11

Gene

tripartite motif containing 16 like (pseudogene)

Gene

GOLGA2 pseudogene 7

Gene

long intergenic non-protein coding RNA 205

Gene

general transcription factor IIi pseudogene 4

Gene

long intergenic non-protein coding RNA 3219

Gene

endogenous Bornavirus like nucleoprotein 3, pseudogene


  • Gene

    H3 clustered histone 7


  • Gene

    MSL complex subunit 3B


  • Gene

    H2A clustered histone 11


  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    GOLGA2 pseudogene 7


  • Gene

    long intergenic non-protein coding RNA 205


  • Gene

    general transcription factor IIi pseudogene 4


  • Gene

    long intergenic non-protein coding RNA 3219


  • Gene

    endogenous Bornavirus like nucleoprotein 3, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.